Additionally, the levels of FPG, ALT, GGT, and ALP as well as the age and BMI of the NAFLD + CHD patients were higher than that in controls, while the levels of HDL and LDL in NAFLD + CHD patients were inferior to that in controls (all P < 0.05). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.